INSIDER
FDA halts use of monoclonal antibodies that don’t work against omicron variant
Read full article: FDA halts use of monoclonal antibodies that don’t work against omicron variantTreatments for people who have become infected with COVID are also being touted by officials as another way for us to reduce the toll COVID-19 is exacting.
Michigan hospitals struggle with staffing to meet rising demand for monoclonal antibodies
Read full article: Michigan hospitals struggle with staffing to meet rising demand for monoclonal antibodiesState officials say their supply of monoclonal antibodies is good enough right now. Still, the demand is high as hospitals struggle to make it available to patients who desperately need it.
Regeneron asks FDA for emergency approval of COVID-19 antibody treatment given to Trump
Read full article: Regeneron asks FDA for emergency approval of COVID-19 antibody treatment given to TrumpThe safety and effectiveness of Regeneron’s antibody treatment have not yet been proven. Regeneron announced Wednesday that it has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration for its COVID-19 antibody treatment. The company says that if the drug is approved, the government has committed to making the drug available to Americans at no cost. Trump has explicitly that he would like to make the drug available and free for everyone. Regeneron says they currently have doses of the drug available for about 50,000 patients and expect to have enough for 300,000 patients within the coming months.